Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Scientific Clinical Research
mi
from
North Miami, FL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Scientific Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Deaconess Health Center
mi
from
Newburgh, IN
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Deaconess Health Center
mi
from
Newburgh, IN
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
ActivMed Practices & Research
mi
from
Methuen, MA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Akron, OH
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Akron, OH
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Patient Priority Clinical sites, LLC
mi
from
Cincinnati, OH
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Patient Priority Clinical sites, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Lindner Center of HOPE
mi
from
Mason, OH
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Lindner Center of HOPE
mi
from
Mason, OH
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Oregon Psychiatric Partners, Llp
mi
from
Eugene, OR
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Oregon Psychiatric Partners, Llp
mi
from
Eugene, OR
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Anderson, SC
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Greer, SC
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials
mi
from
Austin, TX
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials
mi
from
Austin, TX
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Charlottesville Medical Research Inc.
mi
from
Charlottesville, VA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Inc.
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Dean Foundation
mi
from
Middleton, WI
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Dean Foundation
mi
from
Middleton, WI
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Klinische Forschung Berlin-Mitte GmbH
mi
from
Berlin,
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Klinische Forschung Berlin-Mitte GmbH
mi
from
Berlin,
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Florida Clinical Research LLC
mi
from
Bradenton, FL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Florida Clinical Research LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Brain Imaging for HIV-Associated Thinking and Mood Disorders
Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Brain Imaging for HIV-Associated Thinking and Mood Disorders
Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
A Randomized, Placebo-controlled Trial of Minocycline Added to Serotonin Reuptake Inhibitors in Pediatric OCD: Examining the Effects on Clinical Symptoms and on Brain Glutamate Levels Using MRS Imaging
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
A Randomized, Placebo-controlled Trial of Minocycline Added to Serotonin Reuptake Inhibitors in Pediatric OCD: Examining the Effects on Clinical Symptoms and on Brain Glutamate Levels Using MRS Imaging
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
A Randomized, Placebo-controlled Trial of Minocycline Added to Serotonin Reuptake Inhibitors in Pediatric OCD: Examining the Effects on Clinical Symptoms and on Brain Glutamate Levels Using MRS Imaging
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
A Randomized, Placebo-controlled Trial of Minocycline Added to Serotonin Reuptake Inhibitors in Pediatric OCD: Examining the Effects on Clinical Symptoms and on Brain Glutamate Levels Using MRS Imaging
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Quetiapine Pharmacotherapy for Cannabis Dependence
Quetiapine Pharmacotherapy for Cannabis Dependence
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Quetiapine Pharmacotherapy for Cannabis Dependence
Quetiapine Pharmacotherapy for Cannabis Dependence
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated:  12/31/1969
3701 Market Street
mi
from
Philadelphia, PA
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated: 12/31/1969
3701 Market Street
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated:  12/31/1969
Helen O. Dickens Center for Women's Health, Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated: 12/31/1969
Helen O. Dickens Center for Women's Health, Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated:  12/31/1969
Penn Center for Women's Behavioral Wellness
mi
from
Philadelphia, PA
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated: 12/31/1969
Penn Center for Women's Behavioral Wellness
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated:  12/31/1969
Penn Medicine Washington Square (PMWS)
mi
from
Philadelphia, PA
Happy Mommy! Happy Baby! Study
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
Status: Enrolling
Updated: 12/31/1969
Penn Medicine Washington Square (PMWS)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Investigation of Early Life Stress and Depression
Early Life Stress and Depression: Molecular and Functional Imaging Approaches
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
mi
from
Belmont, MA
An Investigation of Early Life Stress and Depression
Early Life Stress and Depression: Molecular and Functional Imaging Approaches
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
An Investigation of Early Life Stress and Depression
Early Life Stress and Depression: Molecular and Functional Imaging Approaches
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
An Investigation of Early Life Stress and Depression
Early Life Stress and Depression: Molecular and Functional Imaging Approaches
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Neurofeedback for Tourette Syndrome
Neurofeedback of Activity in the Supplementary Motor Area for Tourette Syndrome
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Neurofeedback for Tourette Syndrome
Neurofeedback of Activity in the Supplementary Motor Area for Tourette Syndrome
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine
To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine
Status: Enrolling
Updated:  12/31/1969
Ohio Department of Addiction Services
mi
from
Columbus, OH
To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine
To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine
Status: Enrolling
Updated: 12/31/1969
Ohio Department of Addiction Services
mi
from
Columbus, OH
Click here to add this to my saved trials
Implementation of CPT for PTSD in Diverse Communities
Implementation of Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) in Diverse Communities
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital Chelsea Health Center
mi
from
Chelsea, MA
Implementation of CPT for PTSD in Diverse Communities
Implementation of Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) in Diverse Communities
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital Chelsea Health Center
mi
from
Chelsea, MA
Click here to add this to my saved trials
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Click here to add this to my saved trials
Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
A Randomized Comparison of Sublingual Buprenorphine to Morphine Sulfate in the Treatment of Neonatal Abstinence Syndrome (NAS)
Status: Enrolling
Updated:  12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
A Randomized Comparison of Sublingual Buprenorphine to Morphine Sulfate in the Treatment of Neonatal Abstinence Syndrome (NAS)
Status: Enrolling
Updated: 12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care
Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care
Status: Enrolling
Updated:  12/31/1969
Iowa City VA Health Care System, Iowa City, IA
mi
from
Iowa City, IA
Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care
Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care
Status: Enrolling
Updated: 12/31/1969
Iowa City VA Health Care System, Iowa City, IA
mi
from
Iowa City, IA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bellflower, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bellflower, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Beverly Hills, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Costa Mesa, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Garden Grove, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oakland, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orange, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pico Rivera, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Temecula, CA
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Temecula, CA
Click here to add this to my saved trials